Skip to main content
SpringerLink
Log in

Translations in Biobanking: Socio-Material Networks in Health Data Business

  • Chapter
  • First Online:
Society as an Interaction Space

Part of the book series: Translational Systems Sciences ((TSS,volume 22))

Abstract

This study examines commercialization in the context of biomedical R&D, biobanking and personalized medicine as a manifold and transformative texture of socio-material relations in which an innovation—or even a prospect of innovation—is conjoined with and put to the test by multiple human and non-human actors. The empirical study of a Finnish biobank foregrounds the interplay between social and material elements in innovative business. Our analysis unfolds the commercialization of biobank activities as a series of transformations in relations between social, technical and material biobank actors. The study enriches the theorization of commercialization of innovation by addressing the dynamic and malleable nature of socio-material relations as the groundwork of innovation business and by showing how innovation and business become entangled through translations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarikka-Stenroos, L., Sandberg, B., & Lehtimäki, T. (2014). Networks for the commercialization of innovations: A review of how divergent network actors contribute. Industrial Marketing Management, 43, 365–381.

    Article  Google Scholar 

  • Albert, M., Bartlett, J., Randal, N., et al. (2014). Biobank bootstrapping: Is biobank sustainability possible through cost recovery? Biopreservation and Biobanking, 12, 374–380.

    Article  Google Scholar 

  • Callon, M. (1986). Some elements of a sociology of translation: Domestication of the scallops and the fishermen of St Brieuc Bay. In J. Law (Ed.), Power, action and belief: A new sociology of knowledge? London: Routledge.

    Google Scholar 

  • Caulfield, T., & Murdoch, B. (2017). Genes, cells, and biobanks: Yes, there’s still a consent problem. PLoS Biology, 15(7), e2002654.

    Article  Google Scholar 

  • Caulfield, T., Burningham, S., Joly, Y., et al. (2014). A review of the key issues associated with the commercialization of biobanks. Journal of Law and the Biosciences, 1, 94–110.

    Article  Google Scholar 

  • Chalmers, D., Nico, D., Kaye, J., et al. (2016). Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era. BMC Medical Ethics, 17(39). https://doi.org/10.1186/s12910-016-0124-2.

  • Collins, F. (2010). The language of life: DNA and the revolution of personalized medicine. London: HarperCollins.

    Google Scholar 

  • Crossan, M. M., & Apaydin, M. (2010). A multi-dimensional framework of organizational innovation: A systematic review of literature. Journal of Management Studies, 47, 1154–1191.

    Article  Google Scholar 

  • Datta, A., Mukherjee, D., & Jessup, L. (2015). Understanding commercialization of technological innovation: Taking stock and moving forward. R&D Management, 45(3), 215–249.

    Article  Google Scholar 

  • Fortun, M. (2008). Promising Genomics: Iceland and deCODE Genetics in a world of speculation. XXXX. Berkeley, CA: University of California Press.

    Google Scholar 

  • Gaskell, G., Gottweis, H., Starkbaum, J., et al. (2013). Publics and biobanks: Pan-European diversity and the challenge of responsible innovation. European Journal of Human Genetics, 21, 14–20.

    Article  Google Scholar 

  • Geels, F. W. (2010). Ontologies, socio-technical transitions (to sustainability), and the multi-level perspective. Research Policy, 39, 495–510.

    Article  Google Scholar 

  • Gottweis, H., & Petersen, A. (2008). Biobanks. Governance in comparative perspective. London, New York: Routledge.

    Book  Google Scholar 

  • Hedgecoe, A. (2004). The politics of personalised medicine. Cambridge: Cambridge University Press.

    Book  Google Scholar 

  • Helén, I. (2004). Health in prospect. High-tech medicine, life enhancement and the economy of hope. Science Studies, 17(1), 3–19.

    Google Scholar 

  • Hoeyer, K. (2008). The ethics of research biobanking: A critical review of the literature. Biotechnology and Genetic Engineering Reviews, 25, 429–452.

    Article  Google Scholar 

  • Hood, L., & Friend, S. H. (2011). Predictive, personalized, preventive, participatory (P4) cancer medicine. Nature Reviews. Clinical Oncology, 8, 184–187.

    Article  Google Scholar 

  • Hyysalo, S. (2016). Sosiologinen materia: toimijaverkostoteoreettisen tutkimustarinan ohennus. Sosiologia, 53(3), 275–291.

    Google Scholar 

  • Kirchberger, M. A., & Pohl, L. (2016). Technology commercialization: a literature review of success factors and antecedents across different contexts. The Journal of Technology Transfer, 41(5), 1077–1112.

    Article  Google Scholar 

  • Kongsholm, N. C. H., Christensen, S. T., Herrmann, J. R., Larsen, L. A., Minssen, T., Pedersen, L. B., Rajam, N., Tommerup, N., Tupasela, A. M., & Schovsbo, J. H. (2018). Challenges for the sustainability of university-run biobanks. Biopreservation and Biobanking, 16(4), 312–321.

    Article  Google Scholar 

  • Latour, B. (1988). The pasteurization of France. Cambridge, MA: Harvard University Press.

    Google Scholar 

  • Latour, B. (2005). Reassembling the social. Oxford: Oxford University Press.

    Google Scholar 

  • Lauss, G., Snell, K., Bialobrzeski, A., Weigel, J., & Helén, I. (2011). Embracing complexity and uncertainty: An analysis of three orders of ELSA research on biobanks. Genomics, Society and Policy, 7, 47–64.

    Article  Google Scholar 

  • Law, J. (1986). On the methods of long distance control: Vessels, navigation, and the Portuguese route to India. In J. Law (Ed.), Power, action and belief: A new sociology of knowledge? London: Routledge.

    Google Scholar 

  • Law, J. (2007). Actor network theory and material semiotics. Retrieved August 10, 2016, from http://www.heterogeneities.net/publications/Law2007ANTandMaterialSemiotics.pdf.

  • Lehtimäki, H., Helén, I., Snell, K., Eriksson, P., & Montonen, T. (2019). Sustainable value creation in the commercialisation of innovation: The case of Auria biobank. International Journal of Entrepreneurship and Innovation Management, 23(5), 451–465.

    Article  Google Scholar 

  • Markman, G. D., Gianiodis, P. T., & Phan, P. H. (2009). Supply side innovation and technology commercialization. Journal of Management Studies, 46(4), 625–649.

    Article  Google Scholar 

  • Mattila, M., Yrjölä, M., & Lehtimäki, H. (2019). Drivers of and barriers to networked commercialization: Business model perspective. International Journal of Entrepreneurship and Innovation, 23(5), 479–495.

    Google Scholar 

  • Mason, K., Friesl, M., & Ford, C. J. (2018). Markets under the microscope: Making scientific discoveries valuable through choreographed contestations. Journal of Management Studies. https://doi.org/10.1111/joms.12426.

    Article  Google Scholar 

  • Mcmeeking, A., & Harvey, M. (2002). The formation of bioinformatic knowledge markets: An ‘economies of knowledge’ approach. Revue d’économie industrielle, 101(4), 47–64.

    Article  Google Scholar 

  • Miettinen, R. (1998). Materiaalinen ja sosiaalinen. Toiminnan teoria ja toimijaverkkoteoria innovaatioiden tutkimuksen viitekehyksenä. Sosiologia, 35(1), 28–42.

    Google Scholar 

  • Muniesa, F., Millo, Y., & Callon, M. (2007). An introduction to market devices. In M. Callon, Y. Millo, & F. Muniesa (Eds.), Market devices. Malden, MA; Oxford: Blackwell.

    Google Scholar 

  • National Academy of Sciences. (2011). Toward precision medicine. Washington, DC: The National Academies Press.

    Google Scholar 

  • Orlikowski, W. J., & Scott, S. V. (2008). Sociomateriality: Challenging the separation of technology, work, and organization. Academy of Management Annals, 2, 433–474.

    Article  Google Scholar 

  • Parry, B. (2004). Trading the genome: Investigating the commodification of bio-information. New York: Columbia University Press.

    Book  Google Scholar 

  • Prainsack, B. (2017). Personalized medicine. Empowered patients in the 21st century? New York: New York University Press.

    Google Scholar 

  • Raivola, V., Snell, K., Pastila, S., et al. (2018). Blood donors’ preferences for blood donation for biomedical research. Transfusion, 58(7), 1640–1646.

    Article  Google Scholar 

  • Selvitystyö Taysin ja Tyksin erityisvastuualueiden biopankkien yhdistämisestä. (2016). Auria.

    Google Scholar 

  • Snell, K., Starckbaum, J., Lauss, G., et al. (2012). From protection of privacy to control of data streams: A focus group study on biobanks in the information society. Public Health Genomics, 15(5), 293–302.

    Article  Google Scholar 

  • Stokes, D. (1997). Pasteur’s quadrant: Basic science and technological innovation. Washington, DC: Brookings.

    Google Scholar 

  • Sunder Rajan, K. (2006). Biocapital. Durham, London: Duke University Press.

    Book  Google Scholar 

  • Swan, M. (2012). Health 2050: The realization of personalized medicine through crowdsourcing, the quantified self, and the participatory biocitizen. Journal of Personalized Medicine, 2, 93–118.

    Article  Google Scholar 

  • Tang, C. (2016). The data industry. Hoboken, NJ: Wiley.

    Book  Google Scholar 

  • Tarkkala, H. (2019). Reorganizing biomedical research: Biobanks as conditions of possibility for personalized medicine. Doctoral dissertation in Sociology, University of Helsinki.

    Google Scholar 

  • Tarkkala, H., Helén, I., & Snell, K. (2018). From health to wealth: The future of personalized medicine in the making. Futures. https://doi.org/10.1016/j.futures.2018.06.004.

    Article  Google Scholar 

  • Timmons, S., & Vezyridis, P. (2017). Market-driven production of biospecimens and the role of NHS hospital-led biobanks. Sociology of Health Illness, 39(7), 1242–1257.

    Article  Google Scholar 

  • Tupasela, A., & Stephens, N. (2013). The boom and bust cycle of biobanking: Thinking through the life cycle of biobanks. Croatian Medical Journal, 54(5), 501–503.

    Article  Google Scholar 

  • Tupasela, A., Snell, K., & Canada, J. (2015). Patients, business and the state: Translating health information into sustainable benefits (322/2015). Helsinki: Tekes.

    Google Scholar 

  • Turner, A., Dallaire-Fortier, C., & Murtagh, M. (2013). Biobank economics and the ‘commercialization problem. Spontaneous Generations: A Journal for the History and Philosophy of Science, 7(1), 69–80.

    Google Scholar 

  • Tutton, R. (2014). Genomics and the reimaging of personalized medicine. Farnham: Ashgate.

    Google Scholar 

  • Ursin, L., Hoeyer, K., & Skolbekken, J. A. (2008). The informed consenters: Governing biobanks in Scandinavia. In H. Gottweis & A. Petersen (Eds.), Biobanks: Governance in comparative perspective. London: Routledge.

    Google Scholar 

  • Vaught, J., Rogers, J., Carolin, T., & Compton, C. (2011). Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. Journal of the National Cancer Institute Monographs, 242, 24–31.

    Article  Google Scholar 

  • Waeraas, A., & Nielsen, J. (2016). Translation theory ‘translated’: Three perspectives on translation in organizational research. International Journal of Management Reviews, 18, 236–270.

    Article  Google Scholar 

  • Yuille, M. (2011). Infrastructure Vital to Genome Success. Nature, 471, 166.

    Article  Google Scholar 

  • Yuille, M., van Ommen, G.-J., Brechot, C., et al. (2008). Biobanking for Europe. Briefings in Bioinformation, 9, 4–24.

    Google Scholar 

Download references

Acknowledgement

The authors wish to thank the Academy of Finland for financial support (project number 292492) on this project.

Author information

Authors and Affiliations

  1. University of Eastern Finland, Kuopio, Finland

    Ilpo Helén & Hanna Lehtimäki

Authors
  1. Ilpo Helén
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanna Lehtimäki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanna Lehtimäki .

Editor information

Editors and Affiliations

  1. University of Eastern Finland, Kuopio, Finland

    Hanna Lehtimäki

  2. Frisky & Anjoy, Helsinki, Finland

    Petri Uusikylä

  3. Research and Development, Finnish Institute of Occupational Health, Helsinki, Finland

    Anssi Smedlund

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Helén, I., Lehtimäki, H. (2020). Translations in Biobanking: Socio-Material Networks in Health Data Business. In: Lehtimäki, H., Uusikylä, P., Smedlund, A. (eds) Society as an Interaction Space. Translational Systems Sciences, vol 22. Springer, Singapore. https://doi.org/10.1007/978-981-15-0069-5_9

Download citation

Publish with us

Policies and ethics

Search

Navigation